Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (21-30 of 515) with videos related to

Pageof 52
Sort By:
Expert Opinion on Drug Safety|September 30, 2022
An update on the safety of ixazomib for the treatment of multiple myelomaUtkarsh Goel, Shaji Kumar
Clinical Advances in Hematology & Oncology : H&O|March 25, 2010
Review: extramedullary disease in multiple myelomaSumit Madan, Shaji Kumar
American Journal of Hematology|October 17, 2022
Prevention of infections including vaccination strategies in multiple myelomaHeinz Ludwig, Shaji Kumar
Clinical Medicine Insights. Oncology|March 16, 2013
Efficacy of bortezomib as first-line treatment for patients with multiple myelomaUtkarsh Painuly, Shaji Kumar
The New England Journal of Medicine|November 1, 2013
Treatment for high-risk smoldering myelomaAngela Dispenzieri, Shaji Kumar
Oncology and Therapy|February 22, 2021
Post-Transplant Maintenance Treatment Options in Multiple MyelomaDhauna Karam, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2023
Reply to E.R.S. Cliff et alAnita D'Souza, Shaji Kumar
Leukemia & Lymphoma|December 22, 2024
Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the futureSaurabh Zanwar, Shaji Kumar
The Lancet. Oncology|September 16, 2021
Daratumumab for post-ASCT maintenance treatment of myelomaPrashant Kapoor, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2025
A Cure, a Cure, My Kingdom for a Cure…Sagar Lonial, Shaji Kumar
Pageof 52

Showing results (21-30 of 515) with videos related to

Sort By:
Pageof 52
Expert Opinion on Drug Safety|September 30, 2022
An update on the safety of ixazomib for the treatment of multiple myelomaUtkarsh Goel, Shaji Kumar
Clinical Advances in Hematology & Oncology : H&O|March 25, 2010
Review: extramedullary disease in multiple myelomaSumit Madan, Shaji Kumar
American Journal of Hematology|October 17, 2022
Prevention of infections including vaccination strategies in multiple myelomaHeinz Ludwig, Shaji Kumar
Clinical Medicine Insights. Oncology|March 16, 2013
Efficacy of bortezomib as first-line treatment for patients with multiple myelomaUtkarsh Painuly, Shaji Kumar
The New England Journal of Medicine|November 1, 2013
Treatment for high-risk smoldering myelomaAngela Dispenzieri, Shaji Kumar
Oncology and Therapy|February 22, 2021
Post-Transplant Maintenance Treatment Options in Multiple MyelomaDhauna Karam, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2023
Reply to E.R.S. Cliff et alAnita D'Souza, Shaji Kumar
Leukemia & Lymphoma|December 22, 2024
Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the futureSaurabh Zanwar, Shaji Kumar
The Lancet. Oncology|September 16, 2021
Daratumumab for post-ASCT maintenance treatment of myelomaPrashant Kapoor, Shaji Kumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2025
A Cure, a Cure, My Kingdom for a Cure…Sagar Lonial, Shaji Kumar
Pageof 52